The Precision Medicine Clinical Trials in Oncology Symposium was convened at the Grand Hyatt Hotel in Dallas Fort Worth, 8 – 10 November 2017 to help patient advocates in decision making roles learn more about the current state of precision medicine in oncology and to gather input on the design of future precision medicine trials. The specific aims of the Symposium were as follows:
- To employ a framework for gathering feedback from patient advocates about patient issues in precision medicine in oncology.
- To implement the PCORI principles of engagement in development of the symposium and dissemination of the results.
- To facilitate meaningful interaction and idea sharing between advocates and clinical trial leaders that will influence the design of precision medicine trials.
- To Increase the knowledge of advocates in decision making roles about the issues and barriers to precision medicine trials from the patient perspective.
Symposium attendees were 32 advocates from around the United States and 9 speakers representing healthcare practitioners, scientists, advocates, and leaders from the National Cancer Institute.
Day One
The first day of the Symposium was designed to provide information on the current landscape of precision medicine in oncology, including information gleaned from precision medicine trials. Speakers addressed topics related to clinical trial design, accrual, endpoints, and outcomes. Click on each title to access the recording.
- Overview of Precision Medicine: Past, Present and Future - Peter O'Dwyer, MD Speaker
- Designing for the Future: Elements in Precision Medicine Trial Design - Barbara Conley, MD Speaker
- Tumor Profiling: The Good, The Bad and the Future - Stanley R Hamilton, MD Speaker
- NCI-MATCH: Perspectives from Industry Collaborator - Michelle Brockman Speaker
- What We’ve Learned from other Precision Medicine Trials - David Gerber, MD Speaker
Day Two
The second day focused on precision medicine in the community setting, and included perspectives from the NCI Community Oncology Research Program (NCORP; a community-based clinical trials network), physician, and research coordinator.
- Precision Medicine in the Community-NCI NCORP Perspective - Worta McCaskill-Stevens, MD Speaker
- Precision Medicine in the Community- Physician Perspective - James Wade, MD Speaker
Think Tank
A Think Tank was convened on the final day of the Symposium to explore ideas from advocates for future precision medicine trials. Advocates were broken out into small groups to address 3 major issues in precision medicine trials: Communications, Logistics, and Clinical Trial Design. Prior to break out, advocates were polled on subtopics within each major topic area to prioritize them. Please click here to access the report on the Think Tank. Recording is not available at this time. Follow-up on these issues continue with discussions among the participants.
Research Advocacy Network is pleased to acknowledge funding from the following:
This symposium was also partially funded through a Patient Centered Outcomes Research Institute (PCORI)
Eugene Washington PCORI Engagement Award (#6263).
